Verified peer comparison
Vir Biotechnology vs CB Financial Services Financial Comparison
Direct answer
Vir Biotechnology and CB Financial Services are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Vir Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Vir Biotechnology Revenue
- 68,556,000 USD
- CB Financial Services Revenue
- 68,644,000 USD
- Vir Biotechnology Operating income
- -468,020,000 USD
- CB Financial Services Operating income
- 5,300,000 USD